ARS Pharmaceuticals (SPRY) Asset Utilization Ratio (2022 - 2026)

ARS Pharmaceuticals has disclosed Asset Utilization Ratio across 5 years of filings, most recently posting 0.32 for Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.32, up 12.4% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.32 (up 12.4% YoY), and the FY2025 annual result was 0.25, down 18.62% from the prior year.
• Asset Utilization Ratio came in at 0.32 for Q1 2026 at ARS Pharmaceuticals, up from 0.24 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.42 in Q3 2025 to a low of 0.0 in Q1 2024.
• The 5-year median for Asset Utilization Ratio is 0.01 (2024), against an average of 0.14.
• Across the five-year window, Asset Utilization Ratio sank 98.22% in 2024 and jumped 659486.06% in 2025, its largest moves.
• ARS Pharmaceuticals' Asset Utilization Ratio stood at 0.0 in 2022, then slumped by 97.39% to 0.0 in 2023, then surged by 251602.23% to 0.31 in 2024, then retreated by 23.24% to 0.24 in 2025, then soared by 33.72% to 0.32 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.32 (Q1 2026), 0.24 (Q4 2025), and 0.42 (Q3 2025), per Business Quant data.